文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

严重脓毒症与脓毒性休克限制性静脉补液试验(RIFTS):一项随机先导研究

The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论在严重脓毒症与脓毒性休克患者中,限制性静脉补液策略(≤60 mL/kg)可减少72小时补液量,30天死亡率与常规治疗无显著差异。

本研究为前瞻性随机对照先导试验,纳入2016年11月至2018年2月从急诊收入ICU的严重脓毒症与脓毒性休克患者109例,随机分为限制性补液组(55例,前72小时静脉补液≤60 mL/kg)与常规治疗组(54例)。限制性组72小时复苏用液量显著低于常规组(47.1 vs 61.1 mL/kg,p=0.01)。30天死亡限制性组12例(21.8%),常规组12例(22.2%),OR 1.02(95%CI 0.41-2.53)。两组新发器官衰竭、住院或ICU停留时间及严重不良事件均无差异。作者认为限制性策略可成功减少补液量,虽受样本量限制,未观察到死亡率、器官衰竭或不良事件增加,支持在更大规模多中心试验中探索。

要点

  • 限制性补液组72小时复苏用液量显著低于常规组(47.1 vs 61.1 mL/kg,p=0.01)。
  • 30天死亡限制性组12例(21.8%),常规组12例(22.2%),OR 1.02(95%CI 0.41-2.53),无显著差异。
  • 两组新发器官衰竭、住院或ICU停留时间及严重不良事件均无差异。
  • 作者认为限制性静脉补液策略可成功减少补液量,未观察到死亡率、器官衰竭或不良事件增加。
  • 作者建议在更大规模多中心试验中进一步探索限制性静脉补液策略。

适用人群与场景

  • 2016年11月至2018年2月从急诊收入ICU的严重脓毒症与脓毒性休克成人患者,来自一个学术系统内的两家成人急性病医院。

处置流程与药物剂量

  • 限制性静脉补液策略:前72小时静脉补液≤60 mL/kg。
  • 常规治疗:前72小时按常规进行静脉补液。

研究设计与关键结果

  • 研究类型:前瞻性随机对照先导试验,纳入109例,限制性组55例,常规组54例。
  • 限制性组72小时复苏用液量显著低于常规组(47.1 vs 61.1 mL/kg,p=0.01)。
  • 30天死亡:限制性组12例(21.8%),常规组12例(22.2%),OR 1.02(95%CI 0.41-2.53)。
  • 两组新发器官衰竭、住院或ICU停留时间及严重不良事件均无差异。

证据类型、等级与局限

  • 证据类型:前瞻性随机对照先导试验。
  • 局限:样本量有限。

对床旁实践的改变

  • 作者认为限制性静脉补液策略可成功减少严重脓毒症与脓毒性休克患者的静脉补液量。
  • 作者认为虽受样本量限制,未观察到死亡率、器官衰竭或不良事件增加。
  • 作者建议在更大规模多中心试验中进一步探索限制性静脉补液策略。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: It is unclear if a low- or high-volume IV fluid resuscitation strategy is better for patients with severe sepsis and septic shock.

DESIGN: Prospective randomized controlled trial.

SETTING: Two adult acute care hospitals within a single academic system.

PATIENTS: Patients with severe sepsis and septic shock admitted from the emergency department to the ICU from November 2016 to February 2018.

INTERVENTIONS: Patients were randomly assigned to a restrictive IV fluid resuscitation strategy (≤ 60 mL/kg of IV fluid) or usual care for the first 72 hours of care.

MEASUREMENTS AND MAIN RESULTS: We enrolled 109 patients, of whom 55 were assigned to the restrictive resuscitation group and 54 to the usual care group. The restrictive group received significantly less resuscitative IV fluid than the usual care group (47.1 vs 61.1 mL/kg; p = 0.01) over 72 hours. By 30 days, there were 12 deaths (21.8%) in the restrictive group and 12 deaths (22.2%) in the usual care group (odds ratio, 1.02; 95% CI, 0.41-2.53). There were no differences between groups in the rate of new organ failure, hospital or ICU length of stay, or serious adverse events.

CONCLUSIONS: This pilot study demonstrates that a restrictive resuscitation strategy can successfully reduce the amount of IV fluid administered to patients with severe sepsis and septic shock compared with usual care. Although limited by the sample size, we observed no increase in mortality, organ failure, or adverse events. These findings further support that a restrictive IV fluid strategy should be explored in a larger multicenter trial.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Corl KA, Prodromou M, Merchant RC, et al. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study. Crit Care Med. 2019. PMID: 30985449. doi:10.1097/CCM.0000000000003779

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。